Alkermes (ALKS) Interest & Investment Income (2010 - 2026)

Alkermes' (ALKS) quarterly Interest & Investment Income came in at -$568000.0 in Q1 2026, down 210.94% year-on-year from $512000.0 in Q1 2025, and up 98.29% on a QoQ basis from -$33.3 million in Q4 2025.

Alkermes (ALKS) Interest & Investment Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Interest & Investment Income data on file, last reported at -$568000.0 in Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 210.94% year-over-year to -$568000.0 in Q1 2026; TTM through Mar 2026 was -$33.5 million, a 470.06% decrease from a year earlier, with the FY2025 full-year figure at -$133000.0, down 111.64% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at -$568000.0, up from -$33.3 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for ALKS reached as high as $16.7 million in Q4 2022 and fell as low as -$33.3 million in Q4 2025.
  • Historically, Interest & Investment Income has averaged -$88705.9 across 5 years, with a median of $55000.0 in 2025.
  • Across the five-year window, Interest & Investment Income jumped 498.89% in 2023 and slumped 1292.43% in 2025, its largest moves.
  • Year by year, Interest & Investment Income stood at $16.7 million in 2022, then sank by 82.3% to $3.0 million in 2023, then plunged by 180.7% to -$2.4 million in 2024, then slumped by 1292.43% to -$33.3 million in 2025, then surged by 98.29% to -$568000.0 in 2026.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were -$568000.0 in Q1 2026, -$33.3 million in Q4 2025, and $341000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Alkermes 8.78 Bn 8.26 Bn 331.33 Mn -568,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -568,000.00
Dec 31, 2025 -33.31 Mn
Sep 30, 2025 341,000.00
Jun 30, 2025 55,000.00
Mar 31, 2025 512,000.00
Dec 31, 2024 -2.39 Mn
Sep 30, 2024 10.92 Mn
Jun 30, 2024 11,000.00
Mar 31, 2024 -491,000.00
Dec 31, 2023 2.96 Mn
Sep 30, 2023 9.37 Mn
Jun 30, 2023 692,000.00
Mar 31, 2023 2.76 Mn
Dec 31, 2022 16.74 Mn
Sep 30, 2022 -2.35 Mn
Jun 30, 2022 -2.25 Mn
Mar 31, 2022 -4.51 Mn
Dec 31, 2021 -4.33 Mn
Sep 30, 2021 -249,000.00
Jun 30, 2021 -272,000.00